In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
Cg Oncology Inc (NASDAQ: CGON) closed the day trading at $30.15 down -0.46% from the previous closing price of $30.29. In other words, the price has decreased by -$0.46 from its previous closing price. On the day, 0.6 million shares were traded. CGON stock price reached its highest trading level at $30.89 during the session, while it also had its lowest trading level at $30.12.
Ratios:
For a better understanding of CGON, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 35.32 and its Current Ratio is at 35.32. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On October 24, 2024, UBS started tracking the stock assigning a Buy rating and target price of $60.
On September 23, 2024, RBC Capital Mkts started tracking the stock assigning a Outperform rating and target price of $66.RBC Capital Mkts initiated its Outperform rating on September 23, 2024, with a $66 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 13 ’25 when POST LEONARD E sold 1,000 shares for $29.66 per share. The transaction valued at 29,660 led to the insider holds 0 shares of the business.
Song Hong Fang sold 700,000 shares of CGON for $19,600,000 on Dec 16 ’24. The Director now owns 3,003,931 shares after completing the transaction at $28.00 per share. On Dec 16 ’24, another insider, POST LEONARD E, who serves as the Director of the company, sold 1,000 shares for $28.84 each. As a result, the insider received 28,840 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CGON now has a Market Capitalization of 2295310336 and an Enterprise Value of 1498620672. For the stock, the TTM Price-to-Sale (P/S) ratio is 3375.46 while its Price-to-Book (P/B) ratio in mrq is 3.79. Its current Enterprise Value per Revenue stands at 2190.966 whereas that against EBITDA is -15.621.
Stock Price History:
The Beta on a monthly basis for CGON is 1.39, which has changed by -0.15414691 over the last 52 weeks, in comparison to a change of 0.21794415 over the same period for the S&P500. Over the past 52 weeks, CGON has reached a high of $50.23, while it has fallen to a 52-week low of $25.77. The 50-Day Moving Average of the stock is -2.70%, while the 200-Day Moving Average is calculated to be -11.21%.
Shares Statistics:
Over the past 3-months, CGON traded about 703.94K shares per day on average, while over the past 10 days, CGON traded about 650830 shares per day. A total of 67.54M shares are outstanding, with a floating share count of 45.14M. Insiders hold about 33.25% of the company’s shares, while institutions hold 61.82% stake in the company. Shares short for CGON as of 1736899200 were 6374498 with a Short Ratio of 9.06, compared to 1734048000 on 4988157. Therefore, it implies a Short% of Shares Outstanding of 6374498 and a Short% of Float of 8.450000000000001.
